Quality evaluation methods for Transdermal Drug Delivery System (TDDS) pharmaceutical with crystal reservoir system using microscopic Raman, near infrared and terahertz spectroscopy and imaging technique, were developed. The crystal reservoir system that contains an active substance as crystalline form is one of useful release-rate controlling systems for active substances which have high skin-penetration such as tulobuterol (TBR). The conversion of TBR from crystalline form to non-crystalline form in a matrix has important role for a release-rate control. Therefore, crystallization of TBR in a matrix is one of the critical quality factors of this type of TDDS tapes. However, confirmation and/or detection of crystalline TBR in a matrix would be difficult because visual test methods such as a microscopy could not apply through an opaque liner and a supporting board. In this case, non-destructive and high penetrate-able spectroscopic imaging methods would be useful for analyzing it. The authors examined applicability of microscopic spectroscopic imaging methods using laser Raman, near-infrared and terahertz electro-magnetic waves as quality analytical tools for confirming of crystalline TBR in the model tapes and the commercial tapes.

抄録全体を表示

  健康管理に関連した感染症への HCAI Programme（Healthcare Associated Infections Programme：健康管理関連伝染病技術革新プログラム）を予防し削減する基本的方法は，大部分において主な変化はない。HCAI と戦うための主要戦略は，手の衛生・無菌技術，慎重な抗生物質の処方，GCP などに関連したものであるが，新しい幾つかの技術と設備は，より速く，又は，より確実に大きく変えて処理されることを助長することにより，これらの戦略を支援することができる。
  清浄で安全な保護管理¹ で述べられる戦略の一部として，保健省が HCAI 対応技術革新プログラム² に資金を供給している。このプログラムは以下を目標としている。
• さらに HCAI と戦うことを促進するために，技術開発とその採用の速度を上げる
• どの新技術が最高の価値を提供し，最大の影響を及ぼすかを識別する

抄録全体を表示

  The Electronic Records and Electronic Signatures Committee of PDA Japan Chapter, which is abbreviated to be ERES Committee as follows, started with examining and discussing the effect of 21 CFR Part11 which is US regulation about the electronic record/e-signature and the correspondence of the Japanese relevant regulation in November, 2001.
  Thereafter, the ERES committee has been assuming activities as a main target to hold translation/the publication of the references, as well as seminars on ERES so that the pharmaceutical industry could be developed through our efforts to make the most use of the sane corporate development by the electronic technique.
  The committee has approximately 40 members registered now, and it leads and holds some subcommittees, which perform the information sharing between committees, the examination of the measures in the guide and guidelines along with the regulations.
  We hereunder show the achievement of the inspection subcommittee which gave a presentation by the 16th annual PDA Japan Chapter Meeting conducted in November, 2009, as the partial introduction of the ERES committee activity concerned.

抄録全体を表示